Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.48 |
| ▸ | CDC25A | P30304 | 1/20 | 0.48 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.48 |
| ▸ | AKT1 | P31749 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | GMNN | O75496 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | BLM | P54132 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9068058 | 0.90 | LMNA (0.55) | SMN1; SMN2LMNAESR1ADORA3CDC25A | |
| SCHEMBL17370182 | 0.87 | ZDHHC20 (0.39) | SMN1; SMN2LMNAESR1ADORA3CDC25A | |
| SCHEMBL9067631 | 0.82 | SMN1; SMN2 (0.43) | SMN1; SMN2LMNAESR1ADORA3CDC25A | |
| SCHEMBL21987930 | 0.82 | ZDHHC20 (0.36) | SMN1; SMN2LMNAESR1ADORA3CDC25A | |
| SCHEMBL15393542 | 0.81 | SMN1; SMN2 (0.47) | SMN1; SMN2LMNAESR1ADORA3CDC25A | |
| SCHEMBL139079 | 0.78 | SMN1; SMN2 (0.49) | SMN1; SMN2LMNAESR1ADORA3CDC25A | |
| Phosphoric Acid SCHEMBL17105884 | 0.77 | ZDHHC20 (0.49) | LMNAESR1ADORA3CDC25AAGTR1 | |
| Phosphoric Acid SCHEMBL28400128 | 0.77 | ZDHHC20 (0.49) | LMNAESR1ADORA3CDC25AAGTR1 | |
| SCHEMBL10823001 | 0.76 | LMNA (0.57) | SMN1; SMN2LMNAESR1ADORA3CDC25A | |
| SCHEMBL25503763 | 0.76 | ALDH1A1 (0.46) | MAPK1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4121802-B1 | HIGH REFRACTIVE INDEX SILOXANE INSERT MATERIALS FOR EMBEDDED CONTACT LENSES | ALCON INC (CH) | 2024-07-17 | — | — | EP | claimed |
| EP-4076916-B1 | WETTABLE SILICONE HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2024-06-12 | — | — | EP | claimed |
| EP-4121801-B1 | INSERT MATERIALS WITH HIGH OXYGEN PERMEABILITY AND HIGH REFRACTIVE INDEX | ALCON INC (CH) | 2024-04-17 | — | — | EP | claimed |
| EP-4118134-B1 | PHOTOCHROMIC POLYDIORGANOSILOXANE VINYLIC CROSSLINKERS | ALCON INC (CH) | 2024-02-28 | — | — | EP | claimed |
| WO-2023228055-A1 | UV/HEVL-FILTERING CONTACT LENSES | ALCON INC. (CH) | 2023-11-30 | — | — | WO | claimed |
| US-20230374306-A1 | UV/HEVL-FILTERING CONTACT LENSES | ALCON INC. (CH) | 2023-11-23 | — | — | US | claimed |
| US-20230357478-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2023-11-09 | — | — | US | claimed |
| WO-2023209630-A1 | METHOD FOR MAKING SILICONE HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2023-11-02 | — | — | WO | claimed |
| US-20230350100-A1 | METHOD FOR MAKING SILICONE HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2023-11-02 | — | — | US | claimed |
| WO-2023121292-A1 | POLYMER COMPOUND AND APPLICATION THEREOF | 주식회사 삼양사 | 2023-06-29 | — | — | WO | claimed |
| US-10968319-B2 | Silicone hydrogel contact lenses | ALCON INC. (CH) | 2021-04-06 | — | — | US | claimed |
| US-10962803-B2 | Contact lenses with a lubricious coating thereon | ALCON INC. (CH) | 2021-03-30 | — | — | US | claimed |
| US-20200405747-A1 | OPHTHALMIC COMPOSITIONS | ALCON RESEARCH, LLC | 2020-12-31 | — | — | US | claimed |
| WO-2020261185-A1 | OPHTHALMIC COMPOSITIONS | ALCON INC. (CH) | 2020-12-30 | — | — | WO | claimed |
| US-20190300654-A1 | METHOD FOR MAKING SILICONE HYDROGEL CONTACT LENSES | ALCON RESEARCH, LTD. | 2019-10-03 | — | — | US | claimed |
| US-20190263971-A1 | SILICONE HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2019-08-29 | — | — | US | claimed |
| US-20190235277-A1 | CONTACT LENSES WITH A LUBRICIOUS COATING THEREON | ALCON INC. (CH) | 2019-08-01 | — | — | US | claimed |
| US-20140288259-A1 | SURFACE-MODIFIED ULTRAVIOLET BLOCKING POWDER AND ULTRAVIOLET BLOCKING COMPOSITION INCLUDING SAME | KCI CO., LTD. (KR) | 2014-09-25 | — | — | US | claimed |
| US-5461433-A | Cleaning contact lens by immersing in solution containing copolymer where one of the monomers contains phsophate and tertiary ammonium groups | NOF CORPORATION (JP) | 1995-10-24 | — | — | US | claimed |
| EP-0537972-A1 | Treating solution for contact lenses | NOF CORPORATION (JP) | 1993-04-21 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140288259-A1 | SURFACE-MODIFIED ULTRAVIOLET BLOCKING POWDER AND ULTRAVIOLET BLOCKING COMPOSITION INCLUDING SAME | C1QBP, PCTP, CD59 | SMN1; SMN2 4469/4885LMNA 1745/4885ESR1 1530/4885 |
| US-20200405747-A1 | OPHTHALMIC COMPOSITIONS | B4GALT1, B3GAT3, ALG1 | SMN1; SMN2 4174/4885LMNA 1627/4885ESR1 4009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.